Literature DB >> 22206627

Smaller prostate gland size and older age predict Gleason score upgrading.

Boris Gershman1, Douglas M Dahl, Aria F Olumi, Robert H Young, W Scott McDougal, Chin-Lee Wu.   

Abstract

OBJECTIVES: Gleason score is important for prostate cancer (CaP) risk stratification and prognostication but has a significant rate of upgrading. We examined the effect of prostate size and age on upgrading of Gleason 6 CaP.
MATERIALS AND METHODS: A retrospective review was performed of patients with Gleason 6 CaP who underwent radical prostatectomy from 2001 through 2010. Preoperative clinical and pathologic variables were assessed to determine association with risk of upgrading at prostatectomy.
RESULTS: A total of 1,836 patients were identified with Gleason 6 on prostate biopsy. Upgrading was observed in 543 (29.6%) patients with a final Gleason score of 3+4 in 463 (25.2%), 4+3 in 49 (2.7%), and 8-10 in 31 (1.7%). On univariate logistic regression, age, prostate weight, and PSA were significant predictors of Gleason score upgrading and remained significant on multiple logistic regression. Prostate weight was inversely related to risk of upgrading. To further explore this effect, we performed multiple logistic regression to examine risk of Gleason 6, 7, or 8-10 disease in 2,493 patients with Gleason 6-10 at prostatectomy. After controlling for age and PSA, there was a progressively increased risk of Gleason 6, 7, and 8-10 disease with decreasing prostate weight.
CONCLUSIONS: Older age, higher PSA, and smaller prostate gland size are associated with increased risk of Gleason score upgrading. The inverse relationship of prostate weight to risk of Gleason upgrading may be related to increased high-grade disease in smaller glands.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age; Gleason score; Prostate cancer; Size; Upgrading

Mesh:

Substances:

Year:  2011        PMID: 22206627     DOI: 10.1016/j.urolonc.2011.11.032

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  14 in total

1.  Predictors of Gleason score upgrading in a large African-American population.

Authors:  Anup Vora; Tim Large; Jenny Aronica; Sherod Haynes; Andrew Harbin; Daniel Marchalik; Hanaa Nissim; John Lynch; Gaurav Bandi; Kevin McGeagh; Keith Kowalczyk; Reza Ghasemian; Krishnan Venkatesan; Mohan Verghese; Jonathan Hwang
Journal:  Int Urol Nephrol       Date:  2013-07-18       Impact factor: 2.370

2.  Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.

Authors:  Matthew Truong; Jon A Slezak; Chee Paul Lin; Viacheslav Iremashvili; Martins Sado; Aria A Razmaria; Glen Leverson; Mark S Soloway; Scott E Eggener; E Jason Abel; Tracy M Downs; David F Jarrard
Journal:  Cancer       Date:  2013-09-04       Impact factor: 6.860

3.  Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysis.

Authors:  Annika Herlemann; Alexander Buchner; Alexander Kretschmer; Maria Apfelbeck; Christian G Stief; Christian Gratzke; Stefan Tritschler
Journal:  World J Urol       Date:  2017-05-10       Impact factor: 4.226

4.  The effect of prostate weight on the outcomes of robot-assisted radical prostatectomy.

Authors:  Uğur Boylu; Turgay Turan; Cem Başataç; Fikret Fatih Önol; Eyüp Gümüş
Journal:  Turk J Urol       Date:  2013-12

5.  Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6.

Authors:  Hasmet Sarici; Onur Telli; Orhan Yigitbasi; Musa Ekici; Berat Cem Ozgur; Cem Nedim Yuceturk; Muzaffer Eroglu
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 6.  Clinical and pathologic factors predicting reclassification in active surveillance cohorts.

Authors:  Pablo S Sierra; Shivashankar Damodaran; David Jarrard
Journal:  Int Braz J Urol       Date:  2018 Mar-Apr       Impact factor: 1.541

7.  PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy.

Authors:  Tamara L Lotan; Filipe Lf Carvalho; Sarah B Peskoe; Jessica L Hicks; Jennifer Good; Helen Fedor; Elizabeth Humphreys; Misop Han; Elizabeth A Platz; Jeremy A Squire; Angelo M De Marzo; David M Berman
Journal:  Mod Pathol       Date:  2014-07-04       Impact factor: 7.842

8.  Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy.

Authors:  Yuan Gao; Chen-Yi Jiang; Shi-Kui Mao; Di Cui; Kui-Yuan Hao; Wei Zhao; Qi Jiang; Yuan Ruan; Shu-Jie Xia; Bang-Min Han
Journal:  Asian J Androl       Date:  2016 Jul-Aug       Impact factor: 3.285

9.  Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation.

Authors:  Biming He; Rui Chen; Xu Gao; Shancheng Ren; Bo Yang; Jianguo Hou; Linhui Wang; Qing Yang; Tie Zhou; Lin Zhao; Chuanliang Xu; Yinghao Sun
Journal:  Oncotarget       Date:  2016-03-29

10.  The role of prostate-specific antigen density in men with low-risk prostate cancer suitable for active surveillance: results of a prospective observational study.

Authors:  Arcangelo Sebastianelli; Simone Morselli; Ferdinando Daniele Vitelli; Linda Gabellini; Giovanni Tasso; Stefano Venturini; Gianmartin Cito; Graziano Vignolini; Maria Rosaria Raspollini; Mauro Gacci; Sergio Serni
Journal:  Prostate Int       Date:  2019-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.